THE subject which I wish to bring to your attention is the action of various oxytocic substances on the post-partum uterus. Much of the experimental work on which this paper is based has been presented elsewhere, and to-night I intend to approach the subject from a different point of view and endeavour to assess the relative values of the various drugs in common use. It necessarily follows that much of what I have to say is an expression of personal opinion, and I quite expect that some of the statements will be severely criticized. Indeed, I hope that this will be so, for it is only by first setting forth various opinions that definite decisions can eventually be reached.
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In order to restrict the discussion to reasonable limits, the use of drugs in the post-partum period only will be considered, and for the present purpose this period will be taken as meaning the time from delivery to the end of the usual twelve or fourteen days during which the patient is confined to her room. Oxytocic substances are administered during this period for three reasons: (1) To prevent possible occurrence of uterine haemorrhage, (2) to check uterine hamorrhage which has already set in, and (3) to promote involution of the uterus. In order to begin at once with an interesting topic, the last-mentioned therapeutic object will be taken first.
Involution of the Uterus Involution of the uterus, simple as it seems, is in reality a most complicated process. Not only does this apply to the repair of the placental site and of the endometrium, but also more particularly to the means by which the bulk of the myometrium is diminished after parturition. The nature of the degenerative changes in the individual muscle fibres is not clearly understood, but it is evident that an intense destructive activity is present. Muscle fibres which, under the influence of cestrin and other hormonal and mechanical stimuli, have gradually increased in size during the nine gestational months, suddenly atrophy, with the result that, in a few weeks, the uterus shrinks to a twentieth or a twenty-fifth of its original size. It has been said by Whitridge Williams that this change "when compared with changes occurring in acute yellow atrophy of the liver, may well be designated as ' atrophia acutissima.'" Evidence of the intense destructive process is seen in the urinary nitrogen output which, according to the same authority, increases 30 to 50% after the first two or three days of the puerperium and gradually returns to normal when the uterus disappears into the pelvic cavity.
These physiological facts are mentioned in order to focus attention on the essential nature of uterine involution. The process is an active and vital one, and is more than a mere disuse atrophy such as is associated with, say, a broken limb. This brings me now to the point which I wish to emphasize. Uterine involution is too often lightly regarded as being a mechanical process, and by loose reasoning, " a nice hard uterus " becomes the essential feature of good involution. In furtherance of this idea, spasm-producing drugs are freely administered, perhaps on the analogy that as a soft hide subjected to tannin will be converted into useful hard leather, so will a uterus subjected to ergot be induced to shrink into the small firm condition of the non-pregnant organ. Now, to cause contraction or spasm is clearly not a way to aid a process of atrophy and involution of a muscle; moreover, since in the case of the uterus each muscle contraction means a temporarily lessened blood supply, it follows that when spasm is induced the net result must be a compression of the uterine sinuses and a general interference with the free blood supply of the organand this at a time when rapid changes are taking place in the myometrium, necessitating free removal of katabolic products. Such a policy appears to be fundamentally unsound in the case of the normal uterus, and especially so in the case of the infected organ; yet, as we all know, it is for the septic uterus that oxytocic drugs are most freely given. A septic finger is put at rest; too often a septic uterus is whipped into action. (This is a subject on which some interesting comments were made by Dr. Hesketh Roberts [1] a year or two ago.) Speaking for myself, I see no reason why nature should be interfered with during the puerperium. The normal uterus is quite able to look after itself and, left to itself, will contract vigorously at regular intervals. Such contractions ensure that the cavity is kept free of blood-clot, and it is quite possible that these powerful, isolated contractions are superior, in their ability to expel d6bris, to the prolonged spasm so sought-after by some obstetricians. If in a particular case there is evidence of retained lochia it is, of course, desirable to stimulate the uterus, but to this end it would seem better to give spaced doses of a preparation with a vigorous and comparatively brief action rather than to attempt to bring about a sustained uterine spasm.
So much for theory. Is there any direct evidence that involution is aided by drugs ? So far as I know there is none. It will be remembered that some years ago Bourne and Burn [2] described an experiment in which two groups of puerperal patients were dosed with ergot extracts, and a third group was dosed with an inert solution made to resemble liquid extract of ergot. Involution of the uterus was measured daily but no significant difference was found between the three groups-if anything, the control patients showed the quicker involution. More recently DerBrucke [3] has given details of somewhat similar experiments. In this case the patients were given ergot preparations during the first three days of the puerperium. Judging by the published graphs there was again no significant difference between the various groups. Some years ago it was the custom in the obstetric department of University College Hospital to leave administrations of ergot to the discretion of the ward sisters, and in some wards liquid extract of ergot was given to each patient thrice daily during the puerperium. This indiscriminate use of the drug was stopped; the nurses were saved much work; the patients were saved much inconvenience and nausea, the hospital was saved R50 a year and, as far as could be seen, the uteri involuted just as they had done before.
Puerperal Gangrene At this point it is convenient to consider the subject of ergot poisoning. Misuse of ergot may lead to gangrene of the extremities. It is true that this danger is remote and should never appear with reasonable dosage but, unfortunately, ergot is sometimes given unreasonably. For example, it has happened that a patient suffering from puerperal sepsis has been ordered large doses of a potent ergot alkaloid as, for example, ergotamine in the form of femergin (gynergen) tablets.
Days go by, the patient makes slow progress, and after the lapse of weeks it is found that a conscientious nursing-staff is still giving thrice daily doses of ergotamine for the good reason that no one has remembered to counter-order the administration of the drug. In this way patients have received relatively enormous amounts of the alkaloid, and in some instances peripheral, gangrene has developed. A large literature-chiefly German-has accumulated on the subject of puerperal gangrene.
McNalley [4] has collected reports of 17 recent cases of which 12 were stated to have received ergot or ergot derivatives. Wiirth [5] has recorded a further example.
In one case it appears that no less than 174 mgm. of ergotamine tartrate were given in twenty-five days.
It is, however, difficult to be quite certain of the part played by the alkaloid in the production of gangrene, for the condition is sometimes seen quite apart from the administration of ergot-usually in patients suffering from puerperal sepsis.
Proceedings of the Royal Society of Medicine
Dr. Benson of Edinburgh City Hospital, in a private communication, has kindly supplied me with details of 1Q cases of puerperal gangrene. Nine of these patients had received doses of ergotamnine tartrate, the total quantity administered ranging from 7 to 30 mgm., but in a tenth case no ergot in any form had been given, yet similar gangrene appeared. Further cases have been recorded by Wormser [6] , Stein [7] and others. Perusal of this literature shows that the question is not settled, but one is left with the uneasy feeling that a strong suspicion is attached to administration of ergotamine or ergotoxine as one of the causal factors in the production of puerperal gangrene. Surely it is better to err on the side of safety and discourage prolonged administration of these highly potent drugs.
Methods of Recording Uterine Activity
Before discussing the other uses of uterine stimulants it is necessary to say something of the means by which uterine activity may be measured and recorded during the puerperium [8] . There are two simple ways of doing this; one is by an adaptation of Bourne and Burn's well-known method [2] . A small bag containing, when fully distended, about 12 c.c. of water, is mounted on a thin rubber tube strengthened by an internal stylette. The whole is sterilized by boiling and, with full aseptic and antiseptic precautions, is passed gently into the uterine cavity. The bag is connected by water-filled tubing to a recording manometer which traces on a slowly-revolving drum the variations of intra-uterine pressure. From the sixth to the eighth day of the puerperium has been found to be most suitable for the work and, in an experience of nearly 200 such investigations, I have no evidence that this procedure, carried out with gentleness and care, is a source of danger to the patient.
The second apparatus is designed to record changes in the shape of the uterus which can be felt through the abdominal walls, and is a simDlified form of an instrument described by Dodek [9] in 1932. This apparatus has the great merit of simplicity, and causes no discomfort to the patient; moreover it can be used in the early puerperium when it would be rash to introduce a foreign body into the uterus for fear of provoking sepsis. The recordings made by this instrument are a little erratic, and the amplitude of the recorded contractions varies with the stoutness of the abdominal wall and other factors; nevertheless, with increasing experience I have now come to use this method to the exclusion of the other except for those experiments in which an accurate record of intra-uterine tension is required. In what follows, the tracings to be shown of uterine contractions in the first three days of the puerperium were made with the external apparatus, and the tracings during the later puerperium were made with the intra-uterine bag.
With these methods of studying uterine activity it is now possible to obtain accurate information concerning the behaviour of that organ in the post-partum period, and especially of its response to drugs.
Normal Uterine Activity
The smooth muscle tissue of the uterus, like that ofother hollow organs, shows a considerable amount of spontaneous activity. After expulsion of the placenta it contracts strongly and at regular, frequent intervals; this is admirably shown in tracings made by the abdominal apparatus. Incidentally, such tracings are most useful in teaching students and nurses some of the principles on which to conduct normal labour. Too often one finds that it is assumed that when the placenta is expelled, the uterus should become " nice and hard " and steadfastly remain in that firm condition. This belief is, of course, erroneous, and leads to an unnecessary amount of what the late Professor Whitridge Williams was pleased to call " bedevilling of the uterus "-both in the form of unnecessary kneading and squeezing, and also in the form of needless administration of drugs. It is not for a moment denied that the uterus may sometimes relax to a dangerous degree, but abnormal flabbiness is a different matter from a regularly recurring relaxation alternating with contraction, and it is just this point which the tracings serve to illustrate.
To begin with, the contractions occur every five minutes or so; but soon they slow down to half this rate. In the later puerperiunm the contractions, as recorded by the intra-uterine bag, are of medium strength, and usually come at regular intervals of about fifteen minutes. In some cases the uterus will remain inert for three-quarters of an hour or more and then show a moderate activity for a short period; very occasionally the uterus may contract quite erratically both in time and force. An interesting response is sometimes seen as the result of suckling. Quite a decided uterine activity may be induced which will persist for fifteen minutes or so after the baby is taken from the breast. Thus we have an interesting confirmation of the well-known experience that after-pains are often induced by suckling ( fig. 1 ); the mechanism of this sympathetic action is quite unknown.
Intra-uterine injection of 30 c.c. of glycerine: later injection of 10 units of pituitary extract. Time is marked in minutes. The actions of one or two of the less important drugs will now be briefly mentioned as a preliminary to the major consideration of the action of ergot and of pituitary extracts.
Glycerine
For some years intra-uterine injection of glycerine has been freely used for the treatment of uterine sepsis, in the belief that it promotes a free flow of lymph and also in the hope that it will stimulate the uterus to contract and to expel blood-clot and d6bris from its interior. To test this latter possibility a fine catheter was attached to the recording bag and introduced into the body of the uterus. After a preliminary recording, 30 c.c. of glycerine were slowly injected through the catheter. In one case some very feeble contractions were seen, and in three other cases the result was quite negative. A later injection of pituitary extract in one case provoked a brisk response, showing that the uterus was quite capable of strong action if suitably stimulated ( fig. 2 ). It must, therefore, be concluded that intra-uterine injection of glycerine is at least an unreliable method of promoting uterine contraction.
*Reproduced by permission from the Edinburgh Medical Journal.
Gravitol1
"Gravitol" is the proprietary name given to a synthetic substance sponsored by a large manufacturing firm and claimed by them to have an ergot-like action on the uterus and to be a desirable alternative to that drug. Given in the recommended dose of one ampoule (1 c.c. of 1% solution) by intramuscular injection, this substance was found to have a definite but relatively feeble effect for a period of about twenty minutes. Injection of twice the recommended dose had a more decided action ( fig. 3 ), but this was still far short of the response which can be obtained by administration of other better-known oxytocic substances. Histamine
Histamine (called by one firm of manufacturing chemists by the trade-name of "ergamine ") has a curious position in obstetric practice. For long it has been known that histamnine is one of the many active chemical substances present in crude ergot, and, for this reason, it was perhaps natural to suppose that it might be used to reinforce the action of the purified alkaloids. Moreover, since those alkaloids were known to be slow to take effect, there was a hope that the quick-acting histamine would bridge over the gap between the administration of the drug and the onset of the alkaloidal action. Such preparations have been made, and are widely used both for injection and for administration by mouth. It may be said at once that the inclusion of histamine in a preparation intended for oral administration-can have no useful purpose, since no uterine activity can be detected even if large doses are administered in this. manner. When given by injection the matter is more complicated. Histamine has apronounced general action, producing marked blushing, headache and palpitation. It also has a prompt effect on the uterus causing fairly strong contractions which may last for twenty minutes or so. The question to be answered is whether a dose can be found which is large enough on the one hand to produce a uiseful uterine effect, and small enough on the other, to avoid an unpleasant general effect. Some confusion in clinical literature has come about by the substance being spoken of sometimes in terms of a salt and sometimesi in terms of a pure base, and in any account of the action of histamine, the dosage must be very clearly defined. The acid phosphate is the form in which the substance is usually administered, and this weighs roughly three times as much as the pure base. Bourne and Burn [2] have reported that a dose equivalent to at least 1 mgm. of the base is required to produce a definite effect on the parturient uterus. I have corroborated this finding in the case of the puerperal uterus and can add that the 1-Gravitol = diethyl-amino-ethyl-ether of 2-methoxy-6.allyl-phenol. equivalent of 2 mgm. or more is required to produce a useful action. Regarding the side effects, it has been my experience that a dose equivalent to 2 mgm. of the base will always cause unpleasant symptoms, and even half this dose will sometimes upset a patient for a short period. It is thus impossible to give a dose large enough to be therapeutically useful without also producing undesirable side effects. When it is further remembered that histamine produces symptoms very similar to those of surgical shock, it will be realized that this substance is unsuited for administration in obstetrical emergency when the patient is already suffering from shock and blood loss. Fortunately, in the various preparations for clinical use, the dose of the drug appears to be reduced to very small measure. I would, however, suggest that the use of histamine in obstetric practice is an example of the type of mistake which is prone to occur when the precise needs of the clinician are not clearly visualized by the pharmacologist. Ergot Alkaloids: The Ergotoxine-ergotamine Group In 1906, Barger and Carr, working in this country, isolated an active alkaloid ergotoxine." This substance was for many years neglected by clinicians, perhaps because it lacked the backing of efficient publicity such as has been accorded to some later discoveries. In 1918, Stoll, in Switzerland, isolated an almost identical alkaloid, " ergotamine," which, under the trade names of " femergin " and "gynergen," is now freely used by obstetricians the world over. Recently, Wolf, in Hungary, has isolated another alkaloid named " sensibamine "; and still more recently the Kiissner in Germany, has obtained from ergot yet another alkaloid named "ergoclavine." Now, fortunately for us, matters are not nearly so complicated as might be imagined from this list. The alkaloids mentioned-ergotoxine, ergotamine, sensibamine, and ergoclavine-make a well-defined group with regard to their clinical action and, indeed, all observations to date go to show that in this respect they are indistinguishable from each other.
These alkaloids have very large molecules and, perhaps because of this, are slow to take effect when administered in permissible dosage. Thus, when given by mouth no effect is seen in graphic recordings of uterine action until at least thirty-five minutes have elapsed, and usually a very much longer time is required; in some cases no effect has been detected over a period of two hours. Contractions, when they do set in, are small and erratic, and spasm of the uterus is not seen (fig. 4 ).
In fairness, however, it must be stated that it is probable that repeated oral administration may lead to a prolonged heightened irritability of the uterus; whether or not this is a desirable state of affairs is a moot point, and I have already indicated my views on the matter.
Administration of members of the ergotoxine-ergotamine group by intramuscular injection is a more satisfactory procedure. After a lapse of about twenty minutes strong uterine contractions gradually set in which soon merge to produce a fairly well-marked uterine spasm. This spasm is evidenced by a rise in the base-line of the tracings, and lasts for about an hour and a half, after which the intra-uterine tension returns to normal. Regular, strong, isolated contractions now take the place *Reproduced by permission from the British Medical .Tournal.
of the spasm and continue for some hours (fig. 5 ). The exact duration of this second stage cannot be accurately determined because of the limitations of time set on clinical experiments. In some cases, however, it is known that an augmented uterine action has still been present four hours after the administration of the drug. I wish to emphasize certain points concerning the exact nature of the action of ergotoxine, for this is a matter which occasioned some controversy. It has long been known that ergot produces uterine spasm, and it has been too quickly assumed by some that this spasm is caused almost exclusively by the ergotoxine content of the drug. It will later be shown that this is not the case. Nor is the degree of spasm so great as has sometimes been supposed, for, in fact, it is no greater than can be obtained by use of other oxytocic substances, and its duration after permissible dosage is seldom more than one and a half hours. This last statement, in particular, is contrary to current belief, and requires explanation. So far as I have been able to discover, the only clinical evidence in support of a long-standing uterine spasm following the use of this class of drug is described in Bourne and Burn's work [2] . This evidence, however, concerns one case only and one which was, in certain respects, abnormal. One milligram of ergotamine tartrate was given intramuscularly (i.e. twice the usual maximum clinical dose) to a patient during labour. An intra-uterine bag indicated a state of spasm for three hours, after which the recording was discontinued; obstetrical difficulties arose, and finally a retained placenta had to be manually removed. On account of the clinical features of this case, the observers judged that spasm was still present after at least sixteen hours. Now, important as these findings are, I venture to suggest that clinical impressions concerning a single case in which an unusually large amount of the drug was given cannot, by themselves, be accepted as sufficient evidence on which to make a definite pronouncement concerning the clinical action of the drug. Later investigations, repeated many times over, have shown that, in the puerperal uterus at least, spasm does not last longer than about an hour and a half after i mgm. of ergotoxine or ergotamine given intramuscularly.
The New Alkaloid: Ergometrine. So much for the ergotoxine-ergotamine group of alkaloids. Quite recently Dr. H. W. Dudley [11] , of the National Institute for Medical Research at llampstead, has isolated another alkaloid to which the name of "ergometrine " has been given. I have Dr. Dudley's permission to say that its formula appears to be C19H2302N3 (ergotoxine = C35H4106N5). In several respects this new alkaloid stands in strong contrast to those already considered, and its clinical and pharmacological properties show that it must be placed in a class by itself. Clinically, it,is remarkable for rapidity of action which distinguishes it from the ergotoxine-ergotamine group. By mouth an effect is usually seen in five to eight minutes, by intramuscular injection in three to four and a half minutes, and by intravenous injection in about one minute. When given by any of these methods the onset of action is abrupt, and there is well-marked uterine spasm brought about by the partial coalescence of a series of rapid contractions. This stage lasts for about an hour, after which isolated strong contractions occur at regular intervals and continue for one and a half to three hours or more, although for reasons already stated it is difficult to get exact information on this point. It is possible that this stage is not so long as the corresponding stage seen after administration of one of the ergotoxine-ergotamine group (fig. 6 ). The magnitude and the duration of the ergometrine action are, of course, dependent upon dosage and, in the description given, an average dose has been considered. Ergometrine is now on the market in tablet an& 'ampoule form in quantities representing the minimal useful clinical dose. It ;should, however, be realized that when a powerful effect is required in the shortest p_ossible time-as, for example, in cases of post-partum honmorrhage-a larger dose should be employed.
The following probably represent what should generally be used in sach cases: by mouth, 1 mgm.; by intramuscular injection, 0Q5 mgm.; by intravenous injection, 0125 mgm. (figs. 7 and 8). It may be said, however, that these doses have been increased to as much as 1-5 mgm., 075 mgm., and 0O15 mgm. respectively, without symptoms of intolerance appearing. One can thus say with certainty that ergometrine is freer from unpleasant side effects than members of the ergotoxine-ergotamine group, all of which in ordinary clinical dosage not infrequently produce symptoms of depression, headache and nausea. I am also permitted by Sir Henry Dale and Dr. G. L. Brown to state that their investigations of the pharmacology of ergometrine have indicated that this drug is also free from dangerous gangrene-producing properties: in test experiments only a temporary cyanosis of the cock's comb can be obtained.
There is no doubt that ergometrine is the constituent to which aqueous extracts of ergot owe their activity [12] , and it accounts for the clinical action of the B.P. 1914 ext. ergotae liq. about which there was at one time so much discussion 1662 124 ( fig. 4 ). It is also certain that it was the ergometrine action of crude ergot which led to that substance being introduced into midwifery practice some three hundred years ago as a means of accelerating parturition.
In 1813 the following account of the action of ergot decoction was given by Prescott [13] :-" The pains produced by it when a full dose is given, are very peculiarly forcing, and the contractile effort of the uterus continues to that degree, that the fetus is not suffered to retreat, but remains firmly retained where the last exacerbation of the pain left it, until it recurs again. The incessant action will continue if delivery is not effected, for an hour or more, and when it subsides, the medicine, again given, will produce the same effects. The frequency and violence of the uterine effects induced by ergot, are not more extraordinary than its almost instantaneous operation."
Prescott then goes on to give instances of its action appearing in from seven to fifteen minutes of administration of the dose. This description of the clinical action of the old-fashioned decoction has a faithful counterpart in fig. 6 , which depicts the action now known to be characteristic of the purified chemical principle ergometrine. The tracing also clearly indicates the marked spasm which during labour is so dangerous, and which led to the " pulvis ad partum" of the earlier writers being renamed the "pulvis ad mortem." Clinical Use of the Ergot Alkaloids A comparison of the clinical values of the various ergot alkaloids may now be made. The ergotoxine-ergotamine group is distinctly inferior to ergometrine in rapidity of action, but when the action does set in the former alkaloids, if given by injection, produce a spasm of rather longer duration than does ergometrine, the difference being one of about 50%. The total duration of effect is also probably longer in the case of the ergotoxine-ergotamine group. In fairness to ergometrine, however, it must be pointed out that the precise duration of action is not a matter of first-class importance, for if, in some particular case, it is deemed advisable to keep up a long effect, it is a very simple matter to repeat the administration of ergometrine by giving an oral dose either in the form of the pure alkaloid or in the form of an ergot extract of known potency. Keeping these facts in mind, it seems fair to say that in ergometrine we possess a drug which unites the useful clinical properties of the ergotoxine-ergotamine group with other valuable characteristics which these latter alkaloids lack.
The advantages of the quick-acting ergometrine in the treatment of post-partum haemorrhage are obvious; more will be said of this later. Meantime it is convenient to discuss the prophylaxis of post-partum haemorrhage.
When labour is over many obstetricians are in the habit of giving a dose of ergot extract, or an injection of an ergot alkaloid. It is supposed that by doing this the patient can be left alone-overnight perhaps-without fear of uterine bleeding recurring. This procedure, commendable though it is when applied to cases presenting signs of uterine atony, is of questionable value when used as a blind routine. The normal uterus is quite able to look after itself and I have never been able to bring myself to believe that we improve on nature by whipping-up the post-partum organ and causing it to increase its work a hundredfold or more. Further, let us be quite honest in the matter; do we really believe that a single dose of ergot given at the time of delivery will be effective over a period of twelve hours or more? It would seem that such a practice is like locking the stable-door between the hours of, say, 6 and 10 in the evening in order to prevent the horse escaping next morning at 8 o'clock. Would it not be more reasonable to leave a dose of ergot extract or an ergometrine tablet with the patient, instructing her to swallow the medicine in a draught of water should any free bleeding occur ? By this means we should be sure of a maximum effect with uterine spasm within a few minutes of the onset of bleeding. In fact, however, such recurrent bleeding is very rare when the placenta has been expelled normally, and it is seldom that the emergency dose will be used. It may forestall criticism to say now that there is no evidence that roubine administration of ergot after parturition is harmful, but the point to be emphasized is that this practice provokes an intense immediate activity without giving a guarantee of later protection from hemorrhage; moreover, it makes for a state of affairs far removed from the normal physiological behaviour of the uterus.
Third-stage HB&morrhage
A brief digression will now be made in order to touch on the subject of thirdstage hemorrhage, although, strictly speaking, this is outside to-night's discussion. Uterine hoemorrhage, while the placenta is still in situ is at least equal in clinical importance to post-partum hamorrhage. Usually it can be controlled by simple means which need not be discussed now. I wish, however, to suggest that in resistant cases the use of ergometrine is worthy of consideration. This suggestion is made with some hesitation for it is fully realized that, theoretically at least, the drug might cause uterine spasm with retained placenta; but in a desperate case in which haemorrhage must be controlled at all costs, the risk is worth taking, and for this purpose a full dose of ergometrine, such as 0-5 mgm. by intramuscular injection, or better, 0-125 mgm. by intravenous injection should be given. I have not yet had an opportunity of dealing with severe third-stage himorrhage by this means, but I have records of 21 normal cases in which 0*25 orO 5 mgm. of ergometrine has been injected immediately after the birth of the child. In each case the placenta separated in the course of five to ten minutes and was easily expelled from the vagina.' Judging from these records the danger of retained placenta cannot be very great. If it should occur it would probably be best to leave the uterus alone for two hours, if possible, in order that the main effect of the drug should be spent before a Cred6 expulsion or a manual removal of the placenta is attempted. I hope that I will not be misquoted in this matter. I do not advocate the routine use of ergometrine in the third stage of labour, or suggest that it should displace thc simpler methods of controlling hiemorrhage, but I do say that it is worthy of trial if these methods have failed, and especially if the uterine muscle is found to be in a relaxed condition.
Posterior Pituitary Extract The final matter for consideration is the use of posterior pituitary extract, familiarly known by the trade names of "pituitrin," "infundin," &c. In some ways it is more difficult to make a definite pronouncement regarding the clinical value of this substance than of the previously described drugs. Pituitary extract has, as we all know, a most remarkable effect on the uterus, and, for obstetric work, the action is in some ways superior to that of all other oxytocic substances; nevertheless it also has unfavourable characteristics, and these, too, must be taken into consideration before assessing the relative value of the drug.
Pituitary extract exercises its greatest effect on the uterus at term. It has much less effect during pregnancy, and Robson [141 has shown that in the early weeks of gestation it is without action on the isolated human uterine muscle. I have obtained some evidence that the magnitude of the pituitary effect also quickly lessens when parturition is over; after the first week the uterine response is sometimes insignificant, although the exact effect varies greatly from patient to patient. The precise action at this late stage is, however, of little consequence, since the use of pituitary extract is usually restricted to the immediate post-partum period. The rapidity of onset of uterine action after intramuscular injection is very great. It is quite usual for an effect to appear after only two and a half minutes have elapsed. It is sometimes said that pituitary extract produces no spasm but only augments the normal uterine contractions. This is true of small doses only. The usual 5-10 unit dose causes a well-marked spasm for five to ten minutes, after which the uterine contractions are considerably increased in magnitude, and slightly increased in frequency. -The total duration of the effect is usually from half to three-quarters of an hour ( fig. 9 ). In these respects pituitary extract differs considerably from the ergot alkaloids. Patients react in a very varying manner to the drug, and it has been one's clinical experience that pituitary extract is sometimes-although rarely-quite in'effective. Lack of action is not due to "bad" extract, for other injections from the same batch of ampoules, or even from the same bottle, have been found to be fully potent; the variable factor seems to lie in the patient herself. One case will be mentioned. A women whose labour pains ceased after the birth of the first of twins, was given 5-unit doses of pituitary extract at half-hourly intervals. No effect of any kind was seen, nor did labour pains recommence until several hours had elapsed.
Another, and much graver, disadvantage of pituitary extract is that it brings about constriction of the coronary arteries, and physiologists tell ss that under certain circumstances its administration will lessen the cardiac output. If this holds true for clinical work-and there is some reason to believe that it does-then the extract is certainly a double-edged weapon to use in cases of obstetric shock. I have had experience of one case bearing on this point. A patient already severely shocked after operative delivery, was given 10 units of pituitary extract. In a short time the general condition deteriorated; a further dose of 10 units was given; again OCT.-OBSTIET. 3 * the patient's condition changed for the worse, and she died half an hour later. It is, of course, impossible to say from this one case whether the aggravation of the shock was the result of the pituitary administration or merely a coincidence, but since that time I have always made a point of using the purified oxytocic principle, pitocin, in preference to the ordinary extract, in cases of obstetric shock. Pitocin is a pituitary preparation largely freed from the pressor principle to which the undesirable qualities have been ascribed.
Post-partum IHemorrhage
Pituitary extract has long been the sheet-anchor in the treatment of post-partum hemorrhage, and rightly so, for its rapid and intense action is well suited to this condition. Hitherto it has been the only standardized substance available for producing a quick action in this emergency, but with the introduction of ergometrine it now has a serious rival. True, ergometrine does not act so quickly when given by intramuscular injection-three or four minutes are required instead of two and a half minutes in the case of pituitary extract-but ergometrine is well suited for intravenous injection and, given by this route, a uterine response appears in about one minute. Ergometrine also seems to be uniformly reliable and consistent in its action. As yet it is too soon to make a definite pronouncement regarding its usefulness in cases of hwmorrhage and shock, but already one such case has been treated with the drug. After intramuscular injection of 0-6 mgm. satisfactory uterine contractions were observed, and the pulse, which had previously been imperceptible, soon became quite countable at the wrist. Obstetrical shock is therefore no contra-indication to the use of ergometrine, as it is to the use of ordinary pituitary extract.
From a consideration of these various matters it. is justifiable to say that ergometrine is likely to prove a valuable alternative to pituitary extract in the treatment of post-partum himorrhage, and in this and other respects, to be a most useful addition to the obstetrical armamentarium.
I must express my thanks to Professor F. J. Browne, for facilities given in the Obstetric Unit of University College Hospital for carrying out the experimental work on which this paper is based, and to Professor James Young, of the British Post-Graduate Medical School, in whose department part of the work is being continued; also to a loyal nursing-staff, in both institutions, whose help has been invaluable. thing that Mr. Chassar Moir had said. There was no doubt that the routine administration of ergotoxine or ergotamine in the puerperium was a bad thing, as it certainly produced depression and headache. He wondered, however, whether the arguments put forward did not indicate that ergot and its alkaloids had no longer any place in obstetrics at all, since pituitary extract could exert the same kind of effect, and as a normal constituent of the body, should be less harmful. He was very glad to see the evidence that ergometrine produced an effect lasting up to three hours, for the earlier tracings which Mr. Chassar Moir had published indicated an action of much shorter duration, and he accepted the criticism that the evidence for the long duration of the action of ergotamine rested on only one case.
